EE03758B1 - Lahustuvad oksiidid bioloogiliseks kasutamiseks - Google Patents

Lahustuvad oksiidid bioloogiliseks kasutamiseks

Info

Publication number
EE03758B1
EE03758B1 EE9800418A EE9800418A EE03758B1 EE 03758 B1 EE03758 B1 EE 03758B1 EE 9800418 A EE9800418 A EE 9800418A EE 9800418 A EE9800418 A EE 9800418A EE 03758 B1 EE03758 B1 EE 03758B1
Authority
EE
Estonia
Prior art keywords
xerogel
silica
biological use
soluble oxides
gel
Prior art date
Application number
EE9800418A
Other languages
English (en)
Estonian (et)
Other versions
EE9800418A (et
Inventor
Oiva Antero Kurkela Kauko
Ahola Manja
Fagerholm Heidi
Kangasniemi Ilkka
Kiesvaara Juha
Kortesuo Pirjo
Saarinen Niilo
Yli-Urpo Antti
Original Assignee
Orion Corporation
Bioxid Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26691266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03758(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation, Bioxid Oy filed Critical Orion Corporation
Publication of EE9800418A publication Critical patent/EE9800418A/xx
Publication of EE03758B1 publication Critical patent/EE03758B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/10—Ceramics or glasses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/16—Preparation of silica xerogels
    • C01B33/163—Preparation of silica xerogels by hydrolysis of organosilicon compounds, e.g. ethyl orthosilicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Ceramic Engineering (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Silicon Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EE9800418A 1996-05-29 1997-05-29 Lahustuvad oksiidid bioloogiliseks kasutamiseks EE03758B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1857596P 1996-05-29 1996-05-29
US4242397P 1997-03-27 1997-03-27
PCT/FI1997/000330 WO1997045367A1 (en) 1996-05-29 1997-05-29 Dissolvable oxides for biological applications

Publications (2)

Publication Number Publication Date
EE9800418A EE9800418A (et) 1999-10-15
EE03758B1 true EE03758B1 (et) 2002-06-17

Family

ID=26691266

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800418A EE03758B1 (et) 1996-05-29 1997-05-29 Lahustuvad oksiidid bioloogiliseks kasutamiseks

Country Status (18)

Country Link
EP (2) EP1618896A3 (no)
JP (1) JP4322315B2 (no)
CN (1) CN1103320C (no)
AT (1) ATE301102T1 (no)
AU (1) AU738176B2 (no)
CA (1) CA2257172C (no)
CZ (1) CZ297042B6 (no)
DE (1) DE69733889T3 (no)
DK (1) DK0906243T4 (no)
EE (1) EE03758B1 (no)
ES (1) ES2244998T5 (no)
HU (1) HU227939B1 (no)
NO (1) NO328711B1 (no)
NZ (1) NZ332968A (no)
PL (1) PL330191A1 (no)
RU (1) RU2208582C2 (no)
SK (1) SK284193B6 (no)
WO (1) WO1997045367A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980032A0 (fi) * 1998-01-09 1998-01-09 Heikki Matti Eemeli Rauvala Ny anvaendning av en heparin bindande, med tillvaext foerknippad molekyl
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
IL138990A0 (en) 1999-02-12 2001-11-25 Biostream Inc Matrices for drug delivery and methods for making and using the same
ES2290013T3 (es) * 1999-02-22 2008-02-16 Delsitech Oy Fibras de ceramica biodegradables procedentes de soles de silice.
FI19991806A (fi) * 1999-08-25 2001-02-26 Yli Urpo Antti Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
US6632412B2 (en) 1999-12-01 2003-10-14 Timo Peltola Bioactive sol-gel derived silica fibers and methods for their preparation
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
EP1335693A2 (en) 2000-04-21 2003-08-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
AU2002229823B2 (en) * 2001-04-04 2007-02-15 Delsitech Oy Biodegradable carrier and method for preparation thereof
JP4199545B2 (ja) * 2001-04-27 2008-12-17 ビボキシド オサケユイチア 軟組織付着の改善方法、および移植片作製のための該方法の使用
WO2005007802A2 (en) * 2002-03-15 2005-01-27 The Trustees Of The University Of Pennsylvania Fibrous composite for tissue engineering
CN100408026C (zh) * 2003-01-24 2008-08-06 纽约州立大学研究基金会 用于包裹光动力学疗法治疗剂的陶瓷纳米微粒及其使用方法
JP2007500590A (ja) 2003-07-31 2007-01-18 ゾル−ゲル テクノロジーズ エルティーディー． 活性成分が充填されたマイクロカプセル及びその製造方法
US10149825B2 (en) 2004-02-27 2018-12-11 Delsitech Oy Method for preparing adjustably bioresorbable sol-gel derived SiO2
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
JP4006002B2 (ja) * 2004-11-26 2007-11-14 キヤノン株式会社 Ｄｎａ担持繊維及びｄｎａ担持繊維シート並びにこれらの製造方法
BRPI0614143A2 (pt) 2005-08-02 2012-11-20 Sol Gel Technologies Ltd processo para revestir um material particulado insolével em Água, sàlido, com um àxido metÁlico, material particulado revestido, composiÇço, mÉtodo para o tratamento de uma condiÇço superficial em um induvÍduo, e, uso de material particulado revestido
US20080254082A1 (en) 2005-09-27 2008-10-16 Sol-Gel Technologies Ltd. Methods for Crop Protection
EP2021283B1 (en) 2006-05-04 2015-07-08 Agency for Science, Technology and Research Mechanically reversible gel
AU2006344099B2 (en) * 2006-06-06 2013-02-28 Universidad Autonoma Metropolitana Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
DE102007061873A1 (de) 2007-01-15 2008-07-17 Bayer Innovation Gmbh Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien dessen Herstellung und Verwendung
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
JP5344417B2 (ja) * 2007-04-17 2013-11-20 国立大学法人群馬大学 水油界面を利用した薬物−シリカ封入体の製造法
DE102007026043B4 (de) * 2007-06-04 2018-08-16 Jiangsu Synecoun Medical Technology Co., Ltd. Nicht-toxisches Polyethoxysiloxan-Material zur Herstellung von biologisch resorbierbares und/oder bioaktives Polyethoxysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung
DE102007061874A1 (de) * 2007-12-19 2009-06-25 Bayer Innovation Gmbh Nicht-toxisches Polysiloxan-Material zur Herstellung von biologisch resorbierbaren und/oder bioaktiven Polysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung
DE102008033327A1 (de) * 2008-07-16 2010-01-21 Bayer Innovation Gmbh Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik
DE102009053782A1 (de) * 2009-11-19 2011-06-01 BSH Bosch und Siemens Hausgeräte GmbH Poröses SiO2-Xerogel mit charakteristischer Porengröße, dessen trocknungsstabile Vorstufen und dessen Anwendung
DE102009053784A1 (de) * 2009-11-19 2011-05-26 BSH Bosch und Siemens Hausgeräte GmbH Verfahren zur Herstellung eines porösen SiO2-Xerogels mit charakteristischer Porengröße durch ein Bottom-Up-Verfahren über eine Vorstufe mit organischen Festkörperskelettstützen
EP2558424B1 (en) * 2010-04-12 2023-06-07 Université Claude Bernard Lyon I Method for preparing hybrid materials obtained by fast condensation of an organosilicon sol
EP2417982A1 (en) * 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
DE102010034695A1 (de) * 2010-08-18 2012-02-23 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Xerogele mit homogen eingebetteten Lebensmittelzusätzen und Verfahren zur ihrer Herstellung
WO2012058715A1 (en) 2010-11-01 2012-05-10 University Of Technology, Sydney Immune-modulating agents and uses therefor
KR102190009B1 (ko) 2011-12-11 2020-12-15 바우닥스 바이오, 인코포레이티드 비강내 덱스메데토미딘(dexmedetomidine) 조성물 및 그 사용방법
WO2014078435A1 (en) 2012-11-14 2014-05-22 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
HUE047897T2 (hu) 2013-06-24 2020-05-28 Delsitech Oy Szilika tartalmú hidrogél kompozit
CN104546804A (zh) * 2013-10-09 2015-04-29 上海现代药物制剂工程研究中心有限公司 三维网状立体构型的透皮给药制剂及其制备方法
KR102228986B1 (ko) 2015-10-22 2021-03-18 델시테크 오와이 하이드로겔 복합체 데포 제형
GR1010001B (el) * 2019-12-30 2021-05-12 Πυρογενεσις Αβεε Υδρογελες και ξηρογελες φορεις δραστικων συστατικων αποτελουμενες απο δενδριτικα πολυμερη και πυριτια για εφαρμογες επικαλυψης σε στερεα υποστρωματα

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846537A (en) * 1972-08-21 1974-11-05 Monsanto Co Process of preparing silica xerogels
JPH0764543B2 (ja) * 1987-07-24 1995-07-12 富士デヴィソン化学株式会社 球状シリカ及びその製法
IT1216570B (it) * 1988-04-08 1990-03-08 Vectorpharma Int Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
US5200334A (en) * 1991-08-13 1993-04-06 The Regents Of The University Of California Sol-gel encapsulated enzyme
DE4422912A1 (de) * 1994-06-30 1996-01-11 Hoechst Ag Xerogele, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
US5591453A (en) * 1994-07-27 1997-01-07 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses

Also Published As

Publication number Publication date
HUP9903865A3 (en) 2000-06-28
PL330191A1 (en) 1999-04-26
ES2244998T5 (es) 2009-06-15
EP0906243B2 (en) 2009-04-01
NO328711B1 (no) 2010-05-03
NO985534L (no) 1999-01-26
EP0906243A1 (en) 1999-04-07
SK164298A3 (en) 1999-11-08
AU738176B2 (en) 2001-09-13
CZ297042B6 (cs) 2006-08-16
JP2001509122A (ja) 2001-07-10
JP4322315B2 (ja) 2009-08-26
DE69733889D1 (de) 2005-09-08
CA2257172A1 (en) 1997-12-04
CZ384598A3 (cs) 1999-07-14
DE69733889T2 (de) 2006-04-13
DE69733889T3 (de) 2009-10-22
WO1997045367A1 (en) 1997-12-04
EP1618896A3 (en) 2010-07-14
EP1618896A2 (en) 2006-01-25
CN1103320C (zh) 2003-03-19
ES2244998T3 (es) 2005-12-16
NO985534D0 (no) 1998-11-27
DK0906243T3 (da) 2005-10-03
HUP9903865A1 (hu) 2000-04-28
CA2257172C (en) 2005-04-12
HU227939B1 (en) 2012-06-28
RU2208582C2 (ru) 2003-07-20
NZ332968A (en) 2000-08-25
SK284193B6 (sk) 2004-10-05
EE9800418A (et) 1999-10-15
AU2964197A (en) 1998-01-05
CN1219919A (zh) 1999-06-16
ATE301102T1 (de) 2005-08-15
DK0906243T4 (da) 2009-06-08
EP0906243B1 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
EE9800418A (et) Lahustuvad oksiidid bioloogiliseks kasutamiseks
PT946143E (pt) Composicao gelificada a base de nitro-imidazole.
BR9508723A (pt) Implante método de implantação e dispositivo de aplicação
AU2002231058A1 (en) Biologically active agent delivery apparatus and method
ATE547136T1 (de) Therapievorrichtung für wunden
AU9278898A (en) Process for preparing biologically compatible polymers and their use in medical devices
EP0953320A3 (en) Medical device
AU641379B2 (en) Irrigation and suction apparatus usable in endoscopic surgery
WO1997014806A3 (en) Delivery of biologically active polypeptides
DE69633294D1 (de) Gerät zur infusion und aspiration in, bzw. aus knochen
EP0702966A3 (en) Contrast medium delivery systems with patient specific dosage and methods
TR28384A (tr) Flüoroalifatik -ve karboksil- iceren terminal gruplarina sahip polisilokzanlar, bunlarin hazirlanmasi, ve lifli malzemelerin muamelesinde kullanimlari.
CA2241188A1 (en) Hydrogel wound dressing and the method of making and using the same
DE69636507D1 (de) Blutbehälter, sowie Instrument und Gerät zur Abgabe von Blut
DK0543868T3 (da) Sårovertrækssystem
SE9602200D0 (sv) Wound dressing
AU2658195A (en) Immobilization of biologically active materials and diagnostic agents in cross-linked poly(organophosphazenes)
ITRM950439A0 (it) Procedimento ed apparecchio per la erogazione di messaggi in un sistema per comunicazioni.
ATE326199T1 (de) Vorrichtung zur gleichzeitigen austragung von wirkstoffen in den cervikal- und vaginalkanal
GR3035614T3 (en) Use of aromas and flavours to induce or change eating patterns
EP0885848A4 (en) METHOD FOR THE ELECTROCHEMICAL TREATMENT OF AQUEOUS SOLUTIONS AND DEVICE FOR CARRYING OUT SAID METHOD
ITRM940040A0 (it) Dispositivo e procedimento per realizzare protesi dentarie mobili.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

HH1A Change of representative